The stock's fall snapped a two-day winning streak.

"Carelon Services delivered strong results with CareBridge scaling rapidly across dual eligible and high-acuity Medicaid ...

Elevance Health faced a tough crowd as it revealed its Q2 results. Despite a revenue jump to $49.4 billion, up 14% from last year, the adjusted EPS of $8.84 missed the mark by $0.23 according to ...

A digital intervention using the Apple Watch helped people on Medicaid better control their asthma, illustrating the ...

Elevance Health (ELV) just surged a massive 191% in trading volume, turning heads in the stock market. On July 22, 2025, the ...

Fintel reports that on July 21, 2025, Argus Research downgraded their outlook for Elevance Health (NYSE:ELV) from Buy to Hold ...

Argus has downgraded Elevance Health to hold from buy citing pressure on profit margins due to higher medical cost trends in its ACA marketplace and Medicaid businesses.

Q2 2025 Earnings Call Transcript July 17, 2025 Elevance Health Inc. misses on earnings expectations. Reported EPS is $8.84 ...

Signs that the world’s largest economy is holding up lifted stocks a day after speculation about the fate of Federal Reserve ...

Elevance became the fourth major health insurer to lower or scrap its profit forecast, with the CFO call citing a "market-wide morbidity shift." ...

Signs that the world’s largest economy is holding up lifted stocks a day after speculation about the fate of Federal Reserve ...

Elevance Health, Inc. (NYSE:ELV) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 19, Bernstein analyst Lance Wilkes maintained a Buy rating on Elevance Health, Inc.